Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cellcom Israel Ltd. Share Issue/Capital Change 2025

Aug 13, 2025

6724_rns_2025-08-13_752f1b22-ae17-4fed-b4d6-40df9035642f.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

CELLCOM ISRAEL LTD.

CELLCOM ISRAEL LTD.

Registration Number: 511930125

To: Israel Securities Authority To: Tel Aviv Stock Exchange Ltd. Form Number: T087 (Public) Transmitted via MAGNA: 13/08/2025 Israel Securities Authority Website: www.isa.gov.il Tel Aviv Stock Exchange Website: www.tase.co.il Reference: 2025-01-060323

Capital Structure, Grant of Rights to Purchase Shares, and Registers of the Corporation's Securities and Changes Therein

Regulation 31E of the Securities Regulations (Periodic and Immediate Reports), 1970 Regulation 31(a) of the Securities Regulations (Periodic and Immediate Reports), 1970 Regulation 31(b1) of the Securities Regulations (Periodic and Immediate Reports), 1970 Regulation 32 of the Securities Regulations (Periodic and Immediate Reports), 1970

Nature of the Change:

Grant of unregistered options according to a plan for employees.

Explanation: Please briefly describe the nature of the change.

Reference Numbers of Previous Reports on the Subject:

_________, _________, _________.

1. The Corporation's Securities Position After the Change:

Name
and
Type
of
Security
Security
Number
on
TASE
Quantity
in
Registered
Capital
Issued
and
Paid-Up
Capital
Quantity
Registered
in
the
Name
of
the
Registration
Company
Ordinary
Share
1101534 300,000,000 Last
Report:
168,015,280
72,720,788
Current:
168,015,280
Bond
Series
10
1139245 ___ Last
Report:
20,653,400
20,653,400
Current:
20,653,400
Bond
Series
11
1139252 ___ Last
Report:
142,126,800
142,126,800
Current:
142,126,800
Bond
Series
12
1143080 ___ Last
Report:
731,488,236
731,488,236
Current:
731,488,236
Bond
Series
13
1189190 ___ Last
Report:
470,169,250
470,169,250
Current:
470,169,250
Warrants
for
Shares
(Unregistered)
1106038 ___ Last
Report:
5,318,476
0
Current:
7,972,811
Restricted
Share
Units
1159052 ___ Last
Report:
169,866
0
Current:
169,866
Name
and
Type
of
Security
Security
Number
on
TASE
Quantity
in
Registered
Capital
Issued
and
Paid-Up
Capital
Quantity
Registered
in
the
Name
of
the
Registration
Company
Commercial
Papers
1
1203033 ___ Last
Report:
200,000,000
200,000,000
Current:
200,000,000

Explanation: All securities of the company must be detailed, including securities not listed for trading.

2. The Corporation Announces That:

On the date: 13/08/2025

A change occurred in the quantity and register of holders of the corporation's securities (including rights to purchase shares) as a result of:

Description of the nature of the change: Grant of unregistered options according to a plan for employees.

Explanation: Please describe all details of the transaction or action that caused the change in the corporation's securities.

Details:

  • Name of registered holder affected by the change: I.B.I. Equity Compensation and Trusts (2004) Ltd.
  • Type of identification number: Company Registrar Number in Israel
  • Identification number: 513540070
  • Nature of the change: Allocation to employees
  • Date of change: 13/08/2025
  • Executed via the TASE clearinghouse: Yes
  • Type and name of security affected: Warrants for shares (unregistered)
  • Security number on TASE: 1106038
  • Holder's balance in the security in the last report: 5,318,476
  • Holder's balance in the security after the change: 7,972,811
  • Total quantity of securities increased/decreased: 2,654,335
  • Is this a grant of rights to purchase shares: Yes
  • Total consideration for the allocated securities: 0
  • Security number on TASE of the share resulting from exercise: 1101534
  • Number of shares resulting from full exercise/conversion: 2,654,335
  • Total additional consideration from full exercise/conversion: The options will vest in four equal tranches: the exercise price for the first, second, third, and fourth tranches will be 29.36 NIS per share (for further details see section 2.5.2 of the plan).
  • Period during which the securities can be exercised: As detailed in section 2.4.2 of the plan dated 09/02/2025 (Reference: 2025-01-009579).
  • From: 13/08/2026 to: 13/08/2030
  • The allocated securities will be registered for trading: No
  • The allocation of these securities is pursuant to: Employee plan report published on 09/02/2025, reference number: 2025-01-009579
  • Other: Allocation according to the plan dated 09/02/2025 (reference number: 2025-01- 009579). Regarding the number of shares resulting from the exercise of the options - the actual number of shares allocated following the exercise of the options will reflect the monetary benefit embedded in the exercise at the time of exercise (Net Exercise).

Explanations:

    1. If the change affects more than one security, the effect of the change must be detailed in a separate row for each security.
    1. Date of change all changes of the same type, in the same security, performed on the same day, will be summarized in one row. For this purpose – changes performed via the TASE clearinghouse must be separated from those performed directly in the company's books.
    1. The change for a decrease, add the sign "-".
    1. In all quantity fields, the quantity of securities must be entered, not NIS par value.

3. Main Shareholder Register as of the Reporting Date:

No. Name
of
Registered
Shareholder
Type
of
ID
Number
ID
Number
Security
Number
on
TASE
Type
and
Par
Value
of
Shares
Number
of
Shares
Holds
Shares
as
Trustee
1 ___ ___ ___ ___ ___ ___ No
  1. Attached is a file of the shareholder register in accordance with Section 130 of the Companies Law, 1999: CELLCOM_Shareholder_Register_13-08-2025_isa.pdf Alt:CELLCOMShareholderRegister13-08-2025PDF

  2. Attached is an updated file of the corporation's securities registers, including the option holders register and bond holders register: CELLCOM_Securities_Holders_Register_13-08-2025_isa.pdf Alt:CELLCOMSecuritiesHoldersRegister13-08-2025PDF

Authorized Signatories for the Corporation:

No. Name
of
Signatory
Position
1 Larisa
Cohen
Other:
VP
Legal
Counsel
and
Regulation

Explanation: According to Regulation 5 of the Periodic and Immediate Reports Regulations (1970), a report submitted under these regulations must be signed by those authorized to sign on behalf of the corporation. Staff position on the matter can be found on the Authority's website: Click here.

This report does not include reference to the exercise of warrants and restricted share units (RSU) into company shares and the expiration of warrants and RSUs by employees and office holders, which occurred during August 2025 (changes that cumulatively constitute less than 1% of the company's issued capital), and which will be reported in a summary report in the following month in accordance with legal requirements.

Reference numbers of previous documents on the subject (the mention does not constitute incorporation by reference):

Securities of the corporation are listed for trading on the Tel Aviv Stock Exchange

Form structure update date: 06/08/2024

Short name:

Address: HaGavish 10, Netanya 4250708 Phone: 052-9989595, Fax: 09-8607986

Email: cellcom\[email protected]

Previous names of the reporting entity:

Electronic reporter name: Cohen Larisa Position: VP Legal Counsel and Company Secretary Employer company name:

Address: HaGavish 10, Netanya 4250708 Phone: 052-9989595 Fax: 09-8607986 Email: [email protected]